Ken Fisher Fulgent Genetics, Inc. Transaction History

Fisher Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$23.64 - $30.27 $1,725 - $2,209	-73 Reduced 15.18%	408 $11,000
Q3 2023 Nov 13, 2023	BUY	$26.74 - $40.81 $481 - $734	18 Added 3.89%	481 $12,000
Q2 2023 Dec 12, 2023	SELL	$28.52 - $40.7 $513 - $732	-18 Reduced 3.74%	463 $17,000
Q2 2023 Aug 08, 2023	SELL	$28.52 - $40.7 $3,507 - $5,006	-123 Reduced 20.99%	463 $17,000
Q1 2023 Dec 12, 2023	BUY	$29.39 - $36.27 $3,085 - $3,808	105 Added 21.83%	586 $18,000
Q1 2023 May 01, 2023	BUY	$29.39 - $36.27 $17,222 - $21,254	586 New	586 $0

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $513M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.